If I
were a devil creating a malicious virus to cause the most problems for the
human race, the virus would be AIDS. The virus has found the Achilles’ heel of
the immune system.
—Luc Montagnier (Co-Discoverer
of the AIDS Virus), 1988
This shocking exposé reveals how published
methods for manufacturing cross-species cancer viruses were used to create
human versions of monkey immunodeficiency viruses, shortly before AIDS began in
human populations. Eminent cancer virus researchers continued to use these
methods to make HIV more infective for human cells even after the killer virus
had become a deadly international phenomenon.
Immunodeficiency viruses like HIV did not appear on the scene in a historical vacuum. They were designed to do exactly what AIDS does and were optimized for this purpose through decades of animal experiments, prior to their sudden appearance in human populations.
A thorough search of the medical journals, beginning with the early 1960s, reveals that these innovative viruses were invented to enable cancer scientists to unravel the mysteries of how immune system health controlled cancer growth. They did this by selectively disabling components of the immune system, thereby providing vaccine researchers with a “viral scalpel” to dissect the immune response and controllably increase susceptibility to cancer viruses.
In this study, How AIDS Was Invented, the author reveals how these immunodeficiency viruses were systematically engineered to cross the species barrier. It is proposed that documented progress in modifying such viruses for human cell growth was designed to supplement an ongoing line of cross-species cancer vaccine research in which deadly monkey sarcoma viruses were adapted to induce tumors in human subjects with compromised immune systems. (These dangerous and precedent-setting experiments were published in medical journals before the AIDS monkey virus began inducing useful sarcomas on a much larger scale.)
Adding immunodeficiency viruses to such experiments allowed vaccine researchers to replicate, in human populations, a model form of experimentation conducted successfully for decades in animal populations. These experiments employed immunodeficiency viruses to create controlled immune system damage as a means to significantly increase susceptibility to cancer viruses for vaccine research. And this is exactly what has happened with the stunningly useful epidemic of AIDS-induced cancers. This convenient epidemic has not only enabled cancer vaccine researchers to systematically achieve their previously unattainable objectives, such as the identification of long-sought human cancer viruses and the hypothesized immune system weaknesses that govern susceptibility to them. Indeed, the stepwise fulfillment of these essential goals through AIDS research has made international headlines and led numerous observers to predict that scientists will shortly develop human versions of animal cancer vaccines—the “Holy Grail” of cancer researchers who invented and modified immunodeficiency viruses for this very reason.
To
get the explosive story behind How
AIDS Was Invented in e-book format for $3.95, please click
here.
“As disastrous
as the spread of HIV is, the insights that the AIDS epidemic provides into the
causes of cancer may ultimately lead to new and successful approaches to cancer
prevention.”
--European Journal of Cancer, 1991.